Description Results NMA

angioplastie 0.06 [0.03; 0.11]

MACE 0.07 [0.04; 0.11]

CABG 0.09 [0.01; 0.74]

all cause mortality 0.44 [0.03; 6.89]

MI 2.61 [0.32; 21.42]

target lesion revascularisation (TLR ) 0.26 [0.06; 1.07]

Multilink Tetra stent (n=241)

vs.

uncoated Multilink Tetra stent (n=119)

single-blind

Parallel groups

Sample size: 241/119

Primary endpoint: major adverse cardiac events at 30d

FU duration: 6 months

angioplastie 0.06 [0.03; 0.11]

MACE 0.07 [0.04; 0.11]

CABG 0.09 [0.01; 0.74]

all cause mortality 0.44 [0.03; 6.89]

MI 2.61 [0.32; 21.42]

target lesion revascularisation (TLR ) 0.26 [0.06; 1.07]

Multilink Tetra stent (n=241)

vs.

uncoated Multilink Tetra stent (n=119)

single-blind

Parallel groups

Sample size: 241/119

Primary endpoint: major adverse cardiac events at 30d

FU duration: 6 months